ReviewInternational journal of molecular sciences2026
Adipokines as Regulators of Nitric Oxide Synthase Isoforms Across Organs: Emerging Implications for Gastrointestinal Motility.
Review in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Adipose tissue secretes bioactive mediators known as adipokines. Beyond their well-established roles in energy homeostasis, appetite regulation, insulin sensitivity, and inflammation, adipokines have emerged as important modulators of inter-organ communication, influencing cardiovascular, neural, immune, and respiratory functions. Growing evidence indicates that many of these effects involve nitric oxide (NO) signaling. NO is produced by three major nitric oxide synthase (NOS) isoforms: neuronal (nNOS), endothelial (eNOS), and inducible (iNOS). Experimental evidence indicates that leptin, adiponectin, and resistin can modulate NOS expression or activity and NO bioavailability in a tissue- and context-dependent manner. In the gastrointestinal tract, these adipokines can influence nitrergic signaling and motility in
Indexed as
Identifiers
42794803What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.